Onset Dermatologics launches 75mg strength of MINOCIN pellet-filled capsules to treat bacterial infections

Onset Dermatologics, a leader in developing and commercializing prescription products for improving skin health, today announced the launch of a 75mg strength of MINOCIN^® (minocycline hydrochloride) Pellet-Filled Capsules. MINOCIN^® is a tetracycline class antibiotic medicine used to treat infections caused by bacteria. MINOCIN^® may be used along with other agents in the treatment of severe acne.

"MINOCIN^® 75mg offers dermatologists an option for an additional strength that will complement the 50mg and 100mg strengths currently available," said Robert Moccia, President, Onset Dermatologics and CEO, Precision Dermatology. "With three strengths of MINOCIN^®, dermatology practitioners are able to tailor therapy with the original minocycline to meet the needs of many patients."

"Minocycline is a second generation tetracycline commonly used in acne because of its efficacy and ease in dosing. Minocycline is effective in the treatment of acne because it has high tissue penetration, related to the molecule's affinity for lipids such as sebum. Minocycline is readily absorbed whether taken with or without food," said Dr. Neal Bhatia, Associate Professor of Dermatology at Harbor UCLA. "The option of three different strengths of MINOCIN^® enables dermatologists to individualize treatment regimens, balancing efficacy and the potential for adverse events."